Therapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemia

Autor Rai, Kanti R.
Vydáno v J Hematol Oncol (2015)

Alemtuzumab in the up-front setting

Autor Kaufman, Matthew, Rai, Kanti R
Vydáno 2008

Overview of recent developments in chronic lymphocytic leukemia

Autor Jain, Preetesh, Rai, Kanti R
Vydáno 2012

Augmenting NF-κB in poor-risk CLL: A general paradigm for other cancers?

Autor Tuveson, David, Rai, Kanti R.
Vydáno v J Exp Med (2015)

Chronic Lymphocytic Leukemia

Autor Chiorazzi, Nicholas, Chen, Shih-Shih, Rai, Kanti R.
Vydáno v Cold Spring Harb Perspect Med (2021)

Dendritic Cells from Chronic Lymphocytic Leukemia Patients Are Normal Regardless of Ig V Gene Mutation Status

Autor Messmer, Davorka, Telusma, Gloria, Wasil, Tarun, Messmer, Bradley T, Allen, Steven, Rai, Kanti R, Chiorazzi, Nicholas
Vydáno 2004

Peptides That Bind Specifically to an Antibody from a Chronic Lymphocytic Leukemia Clone Expressing Unmutated Immunoglobulin Variable Region Genes

Autor Liu, Yun, Higgins, Chelsea D, Overstreet, Cathie M, Rai, Kanti R, Chiorazzi, Nicholas, Lai, Jonathan R
Vydáno 2013

Chylothorax in Patients With Chronic Lymphocytic Leukemia: A Case Series

Autor Sammartino, Daniel, Khanijo, Sameer, Koenig, Seth, Katsetos, John F., Tufano, Andrea, Rai, Kanti R., Barrientos, Jacqueline C.
Vydáno v J Hematol (2018)

CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells

Autor Damle, Rajendra N., Temburni, Sonal, Calissano, Carlo, Yancopoulos, Sophia, Banapour, Taraneh, Sison, Cristina, Allen, Steven L., Rai, Kanti R., Chiorazzi, Nicholas
Vydáno 2007

FcγRIIb-BCR coligation inhibits B-cell receptor signaling in chronic lymphocytic leukemia

Autor Bosch, Rosa, Mora, Alba, Cuellar, Carolina, Ferrer, Gerardo, Gorlatov, Sergey, Nomdedéu, Josep, Montserrat, Emili, Sierra, Jorge, Rai, Kanti R., Chiorazzi, Nicholas, Moreno, Carol
Vydáno v Haematologica (2020)

Novel Targeted Agents and the Need to Refine Clinical End Points in Chronic Lymphocytic Leukemia

Autor Cheson, Bruce D., Byrd, John C., Rai, Kanti R., Kay, Neil E., O'Brien, Susan M., Flinn, Ian W., Wiestner, Adrian, Kipps, Thomas J.
Vydáno 2012

T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients

Autor Damle, Rajendra N., Temburni, Sonal, Banapour, Taraneh, Paul, Santanu, Mongini, Patricia K. A., Allen, Steven L., Kolitz, Jonathan E., Rai, Kanti R., Chiorazzi, Nicholas
Vydáno 2012

Isolation of malignant B cells from patients with chronic lymphocytic leukemia (CLL) for analysis of cell proliferation: validation of a simplified method suitable for multi-center...

Autor Hayes, Gregory M, Busch, Robert, Voogt, Jason, Siah, Iche M, Gee, Tracy A., Hellerstein, Marc K, Chiorazzi, Nicholas, Rai, Kanti R, Murphy, Elizabeth J
Vydáno v Leuk Res (2009)

The Impact of Initial Fludarabine Therapy on Transformation to Richter’s Syndrome or Prolymphocytic Leukemia in Patients with Chronic Lymphocytic Leukemia: Analysis of an Intergrou...

Autor Solh, Melhem, Rai, Kanti R., Peterson, Bercedis L., Kolitz, Jonathan E., Appelbaum, Frederick R., Tallman, Martin S., Belch, Andrew, Larson, Richard A., Morrison, Vicki A.
Vydáno v Leuk Lymphoma (2012)

Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Stu...

Autor Woyach, Jennifer A., Ruppert, Amy S., Heerema, Nyla A., Peterson, Bercedis L., Gribben, John G., Morrison, Vicki A., Rai, Kanti R., Larson, Richard A., Byrd, John C.
Vydáno 2011

Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes

Autor Sherry, Barbara, Jain, Preetesh, Chiu, Pui Yan, Leung, Ling, Allen, Steven L., Kolitz, Jonathan E., Rai, Kanti R., Barrientos, Jacquie, Liang, Spencer, Hawtin, Rachael, Chiorazzi, Nicholas
Vydáno v Immunol Res (2015)

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer In...

Autor Hallek, Michael, Cheson, Bruce D., Catovsky, Daniel, Caligaris-Cappio, Federico, Dighiero, Guillaume, Döhner, Hartmut, Hillmen, Peter, Keating, Michael J., Montserrat, Emili, Rai, Kanti R., Kipps, Thomas J.
Vydáno 2008

Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin’s lymphoma

Autor Negrea, George O., Elstrom, Rebecca, Allen, Steven L., Rai, Kanti R., Abbasi, Rashid M., Farber, Charles M., Teoh, Nick, Horne, Heather, Wegener, William A., Goldenberg, David M.
Vydáno 2011

Chronic Lymphocytic Leukemia B Cells Can Undergo Somatic Hypermutation and Intraclonal Immunoglobulin V(H)DJ(H) Gene Diversification

Autor Gurrieri, Carmela, McGuire, Peter, Zan, Hong, Yan, Xiao-Jie, Cerutti, Andrea, Albesiano, Emilia, Allen, Steven L., Vinciguerra, Vincent, Rai, Kanti R., Ferrarini, Manlio, Casali, Paolo, Chiorazzi, Nicholas
Vydáno 2002

Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin

Autor Chu, Charles C., Catera, Rosa, Zhang, Lu, Didier, Sebastien, Agagnina, Briana M., Damle, Rajendra N., Kaufman, Matthew S., Kolitz, Jonathan E., Allen, Steven L., Rai, Kanti R., Chiorazzi, Nicholas
Vydáno 2010